KZR
Kezar Life Sciences·NASDAQ
--
--(--)
--
--(--)
KZR fundamentals
Kezar Life Sciences (KZR) released its earnings on Aug 13, 2025: revenue was 0 (YoY --), met estimates; EPS was -1.87 (YoY +37.67%), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-1.87
+37.67%
Report date
Aug 13, 2025
Earnings Call
12:00 PM on Aug 13, 2025
Meeting link.EPS
Actual | -3 | -2.2 | -2.3 | -2.2 | -2.5 | -2.5 | -2.8 | -2.5 | -2.6 | -2.5 | -2.5 | -2.5 | -3.1 | -3.4 | -3.2 | -4.4 | -3 | -3 | -2.78 | -2.77 | -2.27 | -1.87 | |||||||
Forecast | -3.74 | -2.64 | -2.08 | -2.3 | -2.36 | -2.6023 | -2.6333 | -2.96 | -2.8333 | -2.75 | -2.6833 | -2.7617 | -2.8667 | -3.2 | -3.5648 | -3.7954 | -3.3333 | -3.197 | -3.1483 | -2.721 | -2.605 | -2.2364 | |||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +19.79% | +16.67% | -10.58% | +4.35% | -5.93% | +3.93% | -6.33% | +15.54% | +8.23% | +9.09% | +6.83% | +9.48% | -8.14% | -6.25% | +10.23% | -15.93% | +10.00% | +6.16% | +11.70% | -1.80% | +12.86% | +16.38% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7.00M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Forecast | -- | -- | -- | -- | -- | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 166.67K | 0 | 666.67K | 750.00K | 800.00K | 0 | 0 | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +4099.99% | 0.00% | -100.00% | -100.00% | -100.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
Did Kezar Life Sciences beat or miss consensus estimates last quarter?What does Kezar Life Sciences do and what are its main business segments?What factors drove the changes in Kezar Life Sciences's revenue and profit?What is the market's earnings forecast for Kezar Life Sciences next quarter?What were the key takeaways from Kezar Life Sciences's earnings call?What were the key takeaways from Kezar Life Sciences’s earnings call?What is Kezar Life Sciences's latest dividend and current dividend yield?What guidance did Kezar Life Sciences's management provide for the next earnings period?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
